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1. Introduction 
Myocardial infarction is one of the major causes of morbidity and mortality in many 
developed countries. A potential method for treatment of such disease is the cell 
replacement therapy which involves the transplantation of cardiomyocytes (CMs). 
However, CMs are of very limited supply. Embryonic stem cells (ESCs) isolated from the 
inner cell mass of blastocysts are capable of self-renewal and can differentiate into all cell 
lineages, including CMs (He et al., 2003; Kehat et al., 2002; Kehat et al., 2001; Moore et al., 
2008; Mummery et al., 2003; Ng et al., 2010; Thomson et al., 1998; Xu et al., 2002; Xue et al., 
2005). Therefore, ESCs can be an excellent source of CMs for regenerative medicine.  
Calcium (Ca2+) is a universal signaling molecule that regulates a wide variety of cellular 
functions. In CMs, intracellular Ca2+ concentration ([Ca2+]i) plays an important role in the 
contraction and relaxation of CMs. The [Ca2+]i is tightly regulated by many proteins, 
including ion channels, receptors, pumps, and exchangers that are located on the cell surface 
plasma membrane and on the sarcoplasmic reticulum (SR). The aim of this book chapter is 
to provide a thorough review on Ca2+ handling in ESC-derived CMs.  
For each protein of interest, some basic information on the protein was firstly presented. Then, 
changes in the expression of the protein and their contribution to the Ca2+ homeostasis and 
Ca2+ transient as described in human (h) and/or mouse (m) ESC studies were presented. In 
vivo data in mouse embryo studies were also presented for comparison purposes.  
The information reviewed in this chapter would be important not only for understanding 
the basic biology of early differentiating CMs, it would also be important for providing 
insights into the future uses of ESC-derived CMs for cell replacement therapies. 
2.1 Regulation of intracellular calcium level by voltage-operated calcium channels 
Voltage-operated Ca2+ channels are typically composed of five subunits, namely ǂ1, ǂ2, ǃ, δ 
and  (Catterall, 1995; Catterall, 2000; De Waard et al., 1996; Dolphin, 2006; Moreno Davila, 
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1999). The ǂ1 subunit forms the ion conduction pore of the channels while the other subunits 
modulate the functions of the channels. The ǂ1 subunit is itself a tetramer of proteins, each 
of which consists of six transmembrane segments (S1-S6). This subunit confers all of the 
major properties to voltage-operated Ca2+ channels in that it contains a voltage sensor at 
segment S4 and forms a Ca2+-selective pore at segments S5-S6. The other subunits are 
regarded as to providing ancillary functions to the channels. The ǂ2 and δ subunits are two 
products of the same gene; the protein is cleaved into two peptides following translation. 
Subsequent disulfide bond formation anchors the extracellular ǂ2 subunit to the membrane 
via the transmembrane δ subunit. The ǃ subunit is a cytoplasmic protein; it contains an ǂ1-
binding pocket, where specific amino acids in the linker region between segments S1 and S2 
of the ǂ1 subunit bind (Richards et al., 2004). The  subunit is a monomer, which consists of 
four transmembrane segments (S1-S4). A diverse range of functionally distinct voltage-
operated Ca2+ channels are formed by the combinations of different isoforms that have been 
identified for each of these subunits. The ǂ1 subunit is encoded by a family of ten distinct 
genes (the CaV gene family), which can be divided into three sub-families; CaV1 consists of 
CaV1.1-1.4, CaV2 consists of CaV2.1-2.3 and CaV3 consists of CaV3.1-3.3 (Catterall et al., 2005). 
The ǂ2/δ and ǃ subunits are each encoded by four genes; ǂ2/δ1-4 and ǃ1-4 respectively, while 
the  subunit is encoded by eight genes; 1-8 (Arikkath and Campbell, 2003; Yang et al., 2011). 
Voltage-operated Ca2+ channels function by regulating the entry of extracellular Ca2+ into 
cells. Two types of voltage-operated Ca2+ channels exist in adult CMs (Catterall et al., 2005; 
Ono and Iijima, 2005). These are T-type Ca2+ channels, which open in response to more 
negative membrane potentials at about >-70mV for very short durations of 0.5 to 2 
milliseconds (transient activation), and L-type Ca2+ channels, which open in response to less 
negative membrane potentials at about >-30mV for relatively longer periods of 0.5 to 10 
milliseconds (long-lasting activation) (De Waard et al., 1996). 
2.1.1 T-type calcium channels 
T-type Ca2+ channels could be the simplest type of voltage-operated Ca2+ channels known 
thus far. Its structure was initially predicted in silico by homology to other ǂ1 subunits 
known at the time (Perez-Reyes, 2006). Since expression of the synthetic products was able 
to reproduce most of the electrophysiological properties observed in its native form, T-type 
Ca2+ channels were thought to consist of only one ǂ1 subunit; the other ancillary subunits 
(ǂ2, ǃ, δ and ) were considered absent. Although later co-expression studies could describe 
a role for the other ancillary subunits in the regulating functions of T-type Ca2+ channels in 
vitro, presence of these subunits have not been validated in vivo (Dolphin et al., 1999; Dubel 
et al., 2004; Green et al., 2001; Hobom et al., 2000; Lacinova and Klugbauer, 2004). Therefore, 
further investigations will be required to ascertain the genuine structure of this type of 
voltage-operated Ca2+ channel. 
The ǂ1 subunit of T-type Ca2+ channels is encoded by either one of the three CaV3 genes, 
among which CaV3.1 and CaV3.2 are expressed in sinoatrial (SA) nodal cells of the heart 
(Bohn et al., 2000; Perez-Reyes, 2003). The SA node is the primary site, where spontaneous 
rhythmic action potentials are initiated. At the beginning of each action potential in an SA 
nodal cell, an influx of extracellular Na+ into the cytosol, known as the funny current (If), 
first depolarizes the cell to about -50mV, at which T-type Ca2+ channels on the membrane 
open to allow an influx of extracellular Ca2+ into the cytosol. This produces a T-type Ca2+ 
current (ICa, T), which further depolarizes the cell to about -40mV. L-type Ca2+ channels on 
the membrane then open at this membrane potential to allow a greater influx of extracellular 
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Ca2+ into the cytosol and produce an L-type Ca2+ current (ICa, L) to a membrane potential 
until the threshold to produce an action potential is reached. Action potentials generated in 
the SA nodal cells are conducted to CMs within the working myocardium via gap junctions, 
ultimately resulting in regular contractions of the adult heart. 
CaV3.1 mRNA and protein were simultaneously detected as early as embryonic day 14 (E14) 
after the heart has fully matured in vivo within mouse embryos (Cribbs et al., 2001). In a 
separate experiment, the mRNA level of CaV3.1 was moderately reduced from E18 when 
compared to its expression at adult stage (Yasui et al., 2005). Ni2+ at a high concentration of 
100μM could be used to selectively block 50% of CaV3.1 T-type channels. The application of 
Ni2+ at this concentration was found to reduce ICa, T by about 40% in CMs derived from 
mouse embryos at E12.5, indicating that the CaV3.1 T-type channels were functional by this 
time-point (Cribbs et al., 2001). In addition, homozygous null CaV3.1-/- mice displayed 
bradycardia, i.e. a reduced rate of cardiac contraction (Mangoni et al., 2006). Expression of 
CaV3.1 has also been studied in vitro. Its mRNA could be detected as early as day 5 and 
generally increased up until its last measurement at day 15 post-differntiation in ht7 mouse 
ESC- (mESC-) derived CMs (Mizuta et al., 2005). In R1 mESC-derived CMs, however, CaV3.1 
mRNA could only be detected at two copies per cell by day 12, with its expression reaching 
the highest level at day 23 and declining by day 34 post-differentiation; the expression 
pattern reflected the amplitudes of ICa, T measured at these time-points. (Zhang et al., 2003). 
A reduction of about 46% in CaV3.1 expression from day 9.5 to day 23.5 post-differentiation 
was also reported in EMG7 mESC-derived CMs; this down-regulation was found to be 
associated with a decrease in the contraction rates of the CMs in that ICa, T was smaller in 
non-contracting myocytes at day 23.5 when compared to contracting CMs at day 9.5 and 
that the contraction rate at day 9.5 could be reduced via the application of 10μM efonidipine, 
an L- and T-type blocker, to the CMs (Yanagi et al., 2007). These data suggested a role for 
CaV3.1 in regulating the early contractions observed in the developing embryonic heart; by 
maintaining these contractions exclusively in developing pacemaker cells, other cells could 
then develop into non-contracting atrial or ventricular cells.  
CaV3.2 mRNA was detected as early as eight-week gestation in humans (Qu and Boutjdir, 
2001). In mouse, the expression of CaV3.2 was also measured at three time-points; its mRNA 
was detected as early as E9.5 and then its level was decreased by E18 until it was no longer 
detected at adult stage (Yasui et al., 2005). Again, CaV3.2 has been studied in vitro. Its mRNA 
was detected as early as day 5, but peaked at day 6 and gradually declined and was still 
detectable up until the last measurement at day 15 post-differentiation in ht7 mESC-derived 
CMs (Mizuta et al., 2005). In line with this finding, CaV3.2 mRNA level was also found to be 
down-regulated by about 24% from day 9.5 to day 23.5 post-differentiation in EMG7 mESC-
derived CMs (Yanagi et al., 2007). Ni2+ at a low concentration of <50μM could be used to 
selectively block 50% of CaV3.2 T-type channels. When Ni2+ was applied at 40μM to ht7 
mESC-derived CMs at day 8 post-differentiation, ICa, T was found to be evidently decreased 
by about 60%, which signified the presence of functional CaV3.2 T-type channels by this 
time-point. Homozygous null CaV3.2-/- mice showed no sign of cardiac arrhythmia, but 
cardiac fibrosis with age-dependent severity (Chen et al., 2003). These data suggested a role 
for CaV3.2 in regulating the growth and maturation of the developing embryonic heart.  
2.1.2 L-type calcium channels 
L-type Ca2+ channels are distinguished from other voltage-operated Ca2+ channels that open 
at high membrane potentials for long periods on the basis of their sensitivity to 1, 4-
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dihydropyridines (DHPs) (Hess et al., 1984). DHP-binding sites are contained within the ǂ1 
subunit of L-type Ca2+ channels, which are encoded by either one of the four genes of the 
CaV1 sub-family. Among these, CaV1.1 is expressed predominantly in skeletal myocytes, 
CaV1.2 in adult CMs and CaV1.3 exclusively in SA nodal and atrial cells of the heart 
(Catterall, 2000; Qu et al., 2005). Unlike T-type, L-type Ca2+ channels are typical voltage-
operated Ca2+ channels, which are made up of five subunits. Together with one of each of 
the ǂ2/δ1-4, ǃ1-3 and 4, 6-8 ancillary subunits, CaV1.2- and CaV1.3-encoded ǂ1 proteins form the 
functional L-type Ca2+ channels that are found within the adult heart (Freise et al., 1999; 
Hosey et al., 1996; Yang et al., 2011). 
CaV1.2 L-type Ca2+ channels are responsible for cardiac excitation-contraction coupling (E-C 
coupling), a mechanism by which an action potential is transformed into contraction in 
adult CMs. Upon the arrival of an action potential from SA nodal cells, L-type Ca2+ 
channels, which are clustered at transverse tubules (T-tubules), briefly open at the 
sarcolemma to allow an influx of extracellular Ca2+ into the cytosol of the CMs. This only 
accounts for about 30% of the increase in cytosolic Ca2+, which is maintained and magnified 
through a process known as calcium-induced calcium release (CICR) (Bers, 2002). CICR is 
mediated via ryanodine receptor (RyR) Ca2+ release channels, which detect the ICa, L and 
open to release Ca2+ from its intracellular stores within the SR into the cytosol of the CMs. 
This rise enhances binding of Ca2+ to troponin within the CMs, ultimately bringing about 
contractions of the adult heart. Conversely, CaV1.3 L-type Ca2+ channels are responsible for 
producing ICa, L, which constitutes one of the ionic currents to initiate action potentials at the 
SA node. Hence, these L-type Ca2+ channels contribute in maintaining the pacemaker 
activity of the adult heart (see ‘T-type calcium channels’ for details). 
Consistent with its role in E-C coupling in the adult heart, CaV1.2 mRNA was detected as 
early as eight-week gestation in humans, with its level culminating to its maximum at adult 
stage (Qu and Boutjdir, 2001). CaV1.2 mRNA was also present in vitro at <40 days post-
beating in H9.2 human ESC- (hESC-) derived CMs (Satin et al., 2008). In H7 hESC-derived 
CMs, Ca2+ transients that were detected at day 17 post-differentiation could be eliminated 
by the application of 10μM diltiazem, an L-type specific antagonist; this signified the 
functionality of L-type channels by this time-point (Zhu et al., 2009). Similar to humans, the 
expression of CaV1.2 was also up-regulated from its initial detection at E9.5 when the earliest 
contractions were observed by about three-fold at E15.5 when the heart has fully matured in 
mouse embryos; its protein was detected by E12.5 in mouse embryos (Acosta et al., 2004; Xu 
et al., 2003). In mESCs, patch clamp and Ca2+ imaging experiments indicated the functional 
expression of the ICa, L starting from differentiation day 7, even before the appearance of 
spontaneous contractions (Kolossov et al., 1998). The current density of ICa continued to 
increase to day 10, the day of beginning of spontaneous contractions in most differentiating 
embryoid bodies (EBs). Thereafter, similar current density was recorded on day 17, the last 
day of measurement (Kolossov et al., 1998). Homozygous null CaV1.2-/- mice died in utero by 
E14.5, probably due to an absence of CICR-regulated contractions, resulting in reduced 
oxygen supply to the embryos (Seisenberger et al., 2000). Despite the lethality observed, 
normal rhythmic contractions were sustained in the CaV1.2-/- mice until E12.5. For this 
reason, CICR was initially thought to be non-essential for regulating the early cardiac 
contractions observed before E12.5 until later time-points. This conclusion was further 
supported by the fact that both the contractions and Ca2+ oscillations of D3 mESC-derived 
CMs were insensitive to the application of 50nM nisoldipine, a specific L-type channel 
blocker, at days 8-11 post-differentiation (Viatchenko-Karpinski et al., 1999). In addition, 
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these cells were insensitive to the application of high K+ when compared to D3 mESC-
derived CMs at day 16 post-differentiation; exposure to high K+ at this stage would 
normally lead to immediate hyper-contraction and death of these cells. Albeit these findings, 
the notion that ICa, L was not required at earlier stages of development was overthrown 
when evidence for the existence of a compensatory mechanism emerged; the expression of 
CaV1.3 was eminently up-regulated at E9.5 and E12.5 by four fold to produce a DHPR-
insensitive ICa, L in CaV1.2-/- mouse embryos when compared to wild-type (Xu et al., 2003). 
This has not only reinstated the importance of ICa, L in maintaining cardiac contractions, even 
at the embryonic stage of the heart, but also appointed a new role for CaV1.3 to substitute for 
CaV1.2 and preserve its role in CICR for E-C coupling in its absence. In contrast with CaV1.2, 
CaV1.3 mRNA was detected by E9.5, with its level elevated only by a modest amount at 
E15.5 in mouse embryos. Its protein was also detected by E12.5 in mouse embryos (Xu et al., 
2003). Analogous to CaV3.1-/- mice, homozygous null CaV1.3-/- mice developed bradycardia, 
consistent with its primary role in regulating the pacemaker activity of the heart (Platzer et 
al., 2000; Zhang et al., 2002). In R1 mESC-derived CMs, the expression of L-type Ca2+ 
channels could be detected as early as day 7 post-differentiation; given that the application 
of 1μM nifedipine, an L-type channel-specific antagonist, could eliminate Ca2+ transients 
that were normally observed at early (days 9-11) and intermediate (days 13-15), but only 
partially inhibit those at late (18-21 days post-differentiation) stages, this indicated that L-
type channels were, in fact, playing a more dominant role at earlier developmental stages 
(Fu et al., 2006b). 
2.2 Regulation of intracellular calcium level by ligand-operated calcium release 
channels 
2.2.1 Ryanodine receptor (RyR) calcium release channels 
RyR-Ca2+ release channels of a molecular mass of greater than two Mega-Daltons probably 
form the largest ion channels known thus far (Lanner et al., 2010). RyR-Ca2+ release channels 
are composed of homo-tetramers of RyR proteins. Owing to its enormous size, structural 
elucidation of these channels has been a major challenge. Nonetheless, RyR-Ca2+ release 
channels have been predicted to be largely cytoplasmic, with an ion-conducting pore 
consisting of around four to twelve transmembrane segments. 
Three mammalian isoforms of RyRs exist; RyR1 is predominantly expressed in skeletal 
myocytes, RyR2 in CMs and RyR3 in astrocytes. The isoforms differ in three particular 
regions, which have been named domains D1-3 (Ma et al., 2004). As mentioned earlier in 
this chapter, RyR-Ca2+ release channels are induced to open in response to Ca2+ influx via L-
type Ca2+ channels to facilitate E-C coupling in muscle cells. In skeletal myocytes, E-C 
coupling takes place through direct physical interaction between RyR1 and the D2 region, 
which is located between segments S2 and S3 of the CaV1.1-encoded ǂ1 subunit of L-type 
Ca2+ channels. In CMs, however, sequence divergence in the D2 domain between RyR1 and 
RyR2 means that RyR2 cannot physically interact with the CaV1.2-encoded ǂ1 subunit of L-
type Ca2+ channels; E-C coupling can, therefore, only occur via CICR. RyR-Ca2+ release 
channels are, thus, organized into large arrays at junctions between the SR and the 
sarcolemma, in close proximity to the CaV1.2 L-type Ca2+ channels in adult CMs (Bers, 2004). 
Localized Ca2+ release events are referred to as Ca2+ sparks, which are collectively 
synchronized by ICa, L to produce large, whole cell Ca2+ transients in the CMs. 
Release of Ca2+ from the SR stores greatly increases the amount of cytosolic Ca2+ available to 
bind troponins in adult CMs. Adult CMs are mostly occupied by bouquets of thick and thin 
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filaments. Thick filaments are composed of myosin II molecules, while thin filaments are 
made up of troponin, tropomyosin and actin molecules. Troponin is itself a globular 
complex, which consists of three subunits, namely troponin T (TnT), troponin C (TnC) and 
troponin I (TnI). The TnT subunit binds tropomyosin, which coils around strands of actin 
molecules in the thin filament. Binding of Ca2+ to the TnC subunit induces a conformational 
change in the TnI subunit, thereby removing the steric hindrance on actin from 
tropomyosin. Binding of myosin II to actin can then occur, inducing a conformational 
change in the complex. This pulls the actin-associated thin filament pass the myosin II-
associated thick filament, resulting in a contracting phenomenon in the CMs. 
RyR2 protein was present as early as day 17 post-differentiation in H7 hESC-derived CMs 
(Zhu et al., 2009). In H9.2 hESC-derived CMs, the application of a puff of 10mM caffeine was 
able to induce Ca2+ release from the SR as early as day 2 post-beating; this signified the 
functionality of RyR-channels in these cells at this early time-point (Satin et al., 2008). In 
mouse embryos, RyR2 mRNA was detected as early as E8.5, the level of which continued to 
increase up until its last measurement at E16.5 (Rosemblit et al., 1999). Ca2+ release from the 
SR was inducible by the application of 10mM caffeine, indicating the functionality of RyR2 
channels by E8.5 in mouse embryos. In a different study, RyR2 protein was also detected at 
E18 and the detection persisted until adult stage (Liu et al., 2002). Homozygous null RyR2-/- 
mice died at E10, displaying morphological abnormalities in the heart tube (Takeshima et 
al., 1998). RyR2 expression has also been studied in vitro in mESC-derived CMs. RyR2 
mRNA and protein were detected as early as day 5 and day 9 post-differentiation in mESC-
derived CMs respectively (Boheler et al., 2002; Fu et al., 2006a). Immunohistochemistry 
revealed a continuous increase in RyR immunofluorescence intensity in differentiation day 
15-25 CMs compared with differentiation day 8-11 CMs, suggesting an increasing density of 
RyRs during cardiac differentiation (Sauer et al., 2001). The application of 10mM caffeine 
elicited Ca2+ transients, the amplitudes of which increased from day 8 to day 17 post-
differentiation in mESC-derived CMs (Kapur and Banach, 2007). Hence, RyR2 channels 
were functional by day 8 post-differentiation in mESC-derived CMs. RyR2-/- knockout R1 
mESC-derived CMs exhibited no difference in the amplitudes of Ca2+ transients but 
contractions at a reduced rate from early (days 9-11) to intermediate (days 13- 15) to late 
(days 18-21 post-differentiation) differentiation stages when compared with wild-type (Fu et 
al., 2006a; Yang et al., 2002). The applications of 10μM ryanodine and 10mM caffeine were 
able to inhibit and induce Ca2+ release from the SR respectively. Cardiac differentiation was 
not affected, as indicated by the number of contracting colonies present in the differentiating 
cultures. Both effects of ryanodine and caffeine were seen to increase with time post-
differentiation, indicating that SR Ca2+ loads increased during differentiation (Fu et al., 
2006a; Sauer et al., 2001). Altogether, these findings suggested a role for RyR to mediate SR 
Ca2+ release, thereby regulating the rate of the earliest contractions observed in the 
developing embryonic heart, and that this regulation increases with differentiation.  
2.2.2 Inositol 1, 4, 5-trisphosphate Receptor (IP3R) calcium release channels 
IP3R Ca2+ release channels represent a type of enigmatic intracellular Ca2+ channels in that 
both its structure and function(s) are not fully understood (Foskett et al., 2007; Taylor et al., 
2004; Taylor and Tovey, 2010; Yule et al., 2010). IP3R-Ca2+ release channels can be formed 
from either homo- or hetero-tetramers of IP3R proteins. Each subunit of IP3R proteins 
contains an IP3-binding domain at its N-terminus and six transmembrane segments (S1-6) at 
its C-terminus; the Ca2+-selective pore is formed at segments S5-6. Three mammalian 
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isoforms of IP3R exist, namely IP3R1, IP3R2 and IP3R3. These isoforms differ in their binding 
affinities for IP3, with IP3R2 being the most and IP3R3 being the least sensitive to the ligand 
(Iwai et al., 2007; Tu et al., 2005). All three IP3Rs are expressed in human adult CMs, but 
their subcellular localizations have not been studied (Nakazawa et al., 2011; Uchida et al., 
2010). In rat adult CMs, these are expressed at about 50-fold lower than those of RyRs; 
IP3R1s are localized around the nuclear envelope and SR, both of which are connected, 
while IP3R2s are dispersed throughout the cytosol in a punctate pattern (Bare et al., 2005; Li 
et al., 2005; Moschella and Marks, 1993). Thus far, the role of IP3Rs in the adult heart has not 
been defined, but an up-regulation in their expression has been associated with conditions 
of cardiac failure in that the mRNA levels of IP3R1 and IP3R2 were increased by 123% and 
93% respectively in failing compared with normal heart tissues (Ai et al., 2005; Go et al., 
1995). 
Activation of IP3R-Ca2+ release channels is regulated by both the concentration of cytosolic 
Ca2+ ions and the binding of IP3 to one or more of the IP3-binding domains (Iino, 1990; 
Taylor and Laude, 2002). Low concentrations of cytosolic Ca2+ ions are known to activate 
pore opening, while high concentrations inhibit it. IP3 is a second messenger that is 
generated via a G protein-coupled receptor-mediated signal transduction pathway. G 
protein-coupled receptors are transmembrane receptors that are able to sense external 
stimuli and relay these signals into the cell via their interactions with cytosolic G proteins. G 
proteins are heterotrimeric complexes, which consist of a GDP-bound Gǂ subunit and a Gǃ 
dimer. G protein-coupled receptors are classified into different types according to the 
isoform of the Gǂ subunits contained within their G protein-interacting partners. Generation 
of IP3 involves the stimulation of a Gq type of G protein-coupled receptors. Upon 
stimulation with their agonists, a conformational change is induced in the Gq protein-
coupled receptors. This causes an exchange of GDP for GTP in the Gǂ subunits, which then 
dissociate from their Gq protein complexes. GTP-bound Gǂ subunits of Gq protein complexes 
are responsible for activating phospholipase C. It is this enzyme, which hydrolyses 
phosphatidylinositol 4, 5-bisphosphate (PIP2), a phospholipid component of the plasma 
membrane, to ultimately yield IP3 and another second messenger, diacylglycerol (DAG). IP3 
then binds to and activates IP3R-Ca2+ release channels. 
IP3R mRNA was present at detectable levels in D3 mESCs at the undifferentiated state 
(Yanagida et al., 2004). Application of 5μM ATP generated a Ca2+ transient in the 
undifferentiated D3 mESCs, which was inhibited by pre-treatment with 75μM 2-APB, an 
IP3R blocker. This verified the functionality of IP3R-channels in these cells. In H9.2 hESCs, 
immunostaining indicated that both IP3R1 and IP3R2 were expressed in hESC-dervied CMs 
(Sedan et al., 2010; Sedan et al., 2008); and the expression of IP3R2 was shown to gradually 
decline with maturation as revealed by quantitative RT-PCR (Satin et al., 2008). The 
expression of IP3R was also tested during development in vivo; its mRNA was first 
measured and detected as early as E5.5 in mouse embryos; it was present at high levels by 
E8.5 and continued to increase until E16.5 when its level started to drop (Rosemblit et al., 
1999). These were demonstrated to be functional at two time-points; application of 5μM of 
IP3 was able to induce Ca2+ release from the SR in CMs derived from mouse embryos at E5.5 
and E8.5. Application of 5μM xestospongin C, an IP3R antagonist, to mouse embryos at E10 
diminished its Ca2+ spiking; washing the drug out allowed slow recovery of this spiking 
activity (Mery et al., 2005). Likewise, application of 5μM xestospongin C also abrogated the 
Ca2+ spiking activity observed in CGR8 mESC-derived CMs at day 8-10 post-differentiation. 
In addition, during the whole course of cardiac differentiation of R1 mESCs, 2-APB 
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decreased both the amplitude and upstroke velocity of Ca2+ transients, with the inhibitory 
effect decreased as differentiation proceeded, suggesting that IP3R contributes to the Ca2+ 
transient and its effect decreases with differentiation (Fu et al., 2006b). In an attempt to 
discriminate between the roles of RyR- and IP3R2- channels, 50μM ryanodine was first used 
to block RyR-channels before the application of 5-20μM IP3-AM to CMs derived from mouse 
embryos at E10 (Rapila et al., 2008). This was able to induce a Ca2+ leak from the SR of the 
CMs in a concentration-dependent manner, whereby the slopes of the Ca2+ transients were 
elevated, despite its frequency stayed unchanged. In the absence of ryanodine, however, 
application of 10μM IP3-AM led to an increase in the frequency of Ca2+ transients and, 
hence, increased contractions in the CMs at E10. These data suggested a role for IP3R in 
regulating the rate of the earliest contractions observed in the developing embryonic heart, 
perhaps by providing a source of Ca2+ to bind RyRs so as to increase its open probability for 
greater Ca2+ release from the SR, as suggested by Rapila et al. (Rapila et al., 2008) In support 
of this finding, genetic knockdown of IP3R in CGR8 mESC-derived pacemaker cells resulted 
in weak and infrequent contractions, although differentiation was not affected, whilst mice 
over-expressing the IP3R2 gene developed mild cardiac hypertrophy by three months of age 
(Mery et al., 2005; Nakayama et al., 2010). 
2.3 Regulation of intracellular calcium level by exchanger and pump 
As previously mentioned, upon arrival of cardiac action potential, activation of L-type Ca2+ 
channel followed by CICR increases [Ca2+]i for the contraction process. Subsequently, the 
excess Ca2+ has to be removed in order to initiate relaxation. In CMs, this Ca2+ removal 
process is mediated by different Ca2+ extrusion mechanisms via the action of sodium-
calcium exchanger (NCX) and sarcoplasmic/endoplasmic reticulum Ca2+-ATPase (SERCA). 
2.3.1 Sodium-calcium exchanger (NCX)  
NCX contains 9 transmembrane segments with a large loop at the cytoplasmic side 
(Philipson and Nicoll, 2000). Mutation experiments demonstrated the importance of -
helices in the transmembrane segments for the transport activity of NCX (Nicoll et al., 1996). 
The large intracellular loop is found to be not essential for the transport; however, it is 
important for catalyzing the ion translocation reaction and has important regulatory 
functions (Philipson and Nicoll, 2000). This loop consists of multiple regulatory sites, 
including the regulatory Ca2+ binding site and the exchanger inhibitory peptide (XIP) 
region. The activity of NCX is known to be regulated by at least 4 factors, including Ca2+ 
(DiPolo, 1979), Na+ (Hilgemann et al., 1992), PIP2 (Hilgemann, 1990), and phosphorylation 
(Iwamoto et al., 1996). Binding of Ca2+ to the Ca2+ binding site is required for activating the 
Na+-Ca2+ exchange activity (Giladi et al., 2010; Ottolia et al., 2004; Wu et al., 2010). On the 
other hand, the XIP region is responsible for the Na+-dependent inactivation and is involved 
in the elimination of the Na+-dependent inactivation process by PIP2 (Matsuoka et al., 1997). 
The activity of NCX is also regulated by phosphorylation, with stronger phosphorylation 
leading to higher NCX activity (Reppel et al., 2007a). Requirements of direct 
phosphorylation for up-regulation of NCX function by PKA and PKC are still in debate. A 
recent study by Wanichawan et al. demonstrated that the PKA phosphorylation site in full-
length NCX1 is inaccessible, suggesting that NCX1 is not a direct substrate of PKA 
(Wanichawan et al., 2011). On the other hand, another study showed that the activity of 
NCX1 is dependent on PKC, although direct phosphorylation by PKC is not required 
(Iwamoto et al., 1998). NCX exists in 3 different isoforms, namely NCX1, NCX2 and NCX3. 
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NCX1 is referred as the cardiac NCX isoform as it is highly expressed in CMs but only in a 
lesser extent in other tissues such as brain and kidney (Lee et al., 1994).  
NCX is classified as a secondary active transporter, which uses the energy stored in the 
electrochemical gradient in Na+ to extrude Ca2+ out of the cells, while the electrochemical 
gradient of Na+ is maintained by the Na+/K+-ATPase. Under normal condition, NCX 
operates in the forward mode in which it constitutively brings 3 Na+ into the cells and 
extrudes 1 Ca2+ in each translocation cycle. The forward mode is stimulated in response to a 
rise in [Ca2+]i, and it serves to bring [Ca2+]i back to normal level. In CMs, the primary role of 
NCX is to extrude Ca2+ after excitation under normal physiological conditions (Philipson 
and Nicoll, 2000). Some studies also showed that NCX functions in shaping the cardiac 
action potential. Application of NCX blocker KB-R7943 leads to shortening of plateau phase 
of cardiac potential (Spencer and Sham, 2003); similarly, CMs from NCX knockout mice also 
has a shorter AP when compare to wild-type mice (Pott et al., 2005), while induced over-
expression of NCX leads to a longer plateau (Wang et al., 2009). On the other hand, NCX 
also operates in the reverse mode in response to membrane depolarization in CMs. During 
the depolarization phase of action potential when the [Ca2+]i has not reached the peak of 
Ca2+ transients, the reverse mode is predominant (Sah et al., 2003). Ca2+ influx via the 
reverse mode of NCX has been suggested to act synergistically with Ca2+ influx via L-type 
Ca2+ channels to trigger Ca2+ release from the SR as ICa, L are small at depolarized membrane 
potential (Sah et al., 2003). In addition, NCX can positively regulate SR Ca2+ load via the 
reverse mode action (Hirota et al., 2007). Interestingly, under pathophysiological conditions 
such as cardiac failure, NCX also operates in the reverse mode to allow additional Ca2+ 
influx for contraction in order to compensate for the reduction in Ca2+ release from SR 
(Gaughan et al., 1999).  
NCX is found to be essential for embryo development. Several studies showed that NCX1 is 
expressed restrictedly in the embryonic heart during early development. NCX knockout are 
embryonic lethal at ~9-11 days post coitum with immature heart development (Cho et al., 
2000; Koushik et al., 2001; Reuter et al., 2003; Wakimoto et al., 2000). Molecular studies 
demonstrated that NCX mRNA expresses before the appearance of spontaneously beating 
mESC-CMs; the expression persists thereafter in the CMs (Fu et al., 2006b). It is suggested that 
expression of NCX at that early stage is essential for early EC-coupling as SR is not well-
developed at that stage, NCX is hence essential for maintaining the proper Ca2+ homeostasis 
even in the very early stage cardiac development (Reppel et al., 2007a; Reppel et al., 2007b).  
Two approaches were used to demonstrate the functional expression of NCX in ESC-CM. In 
Otsu et al. (Otsu et al., 2005), function of NCX was indirectly assessed by using high 
concentration of NCX blocker KB-R7943. Application of KB-R7943 induced sustained 
elevation of [Ca2+]i, and this elevation increased as differentiation of mESC-CMs proceeded 
(Otsu et al., 2005). Apart from using pharmacological blocker, direct measurement of NCX 
activity was performed by using patch-clamping. INCX was found to be increased as hESC-
CMs developed from day 7+40 to day 7+90 (Fu et al., 2010). However, CMs derived from 
murine embryonic heart at late stage (E16.5) showed a significantly lower INCX density when 
compared to CMs at early stage (E10.5) (Reppel et al., 2007a), probably due to the high 
phosphorylation status of NCX in early stage. Consistently, upon differentiation, the 
proportion of Ca2+ extrusion by NCX declined from day 9 to day 17 in mESC-CMs (Kapur 
and Banach, 2007). The discrepancy between different studies on the absolute functional 
expression of NCX as development proceeds is unknown. Nonetheless, it is clear that NCX 
is important for Ca2+ extrusion in differentiating CMs and the decreased contribution by 
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NCX to Ca2+ extrusion as development proceeds may be explained by the gradual 
development of SERCA on the SR.  
In the study by Fu et al., the basal [Ca2+]i of mESC-CMs in both early and late developmental 
stages was increased after applying Na+-free solution, suggesting that NCX is functional in 
maintaining Ca2+ homeostasis (Fu et al., 2006b). Interestingly, Na+-free solution completely 
blocked the Ca2+ transients in CMs from late developmental stage but not the CMs from 
early developmental stage, suggesting that NCX starts to regulate Ca2+ transients only in the 
late developmental stage (Fu et al., 2006b). Similar results were obtained from hESC-CMs 
(Fu et al., 2010). Basal [Ca2+]i was marginally increased in CMs at day 7+90 after applying 
Na+-free solution, but the same was not observed in CMs at day 7+40. In addition, irregular 
Ca2+ transient pattern was observed in day 7+90 CMs treated with Na+-free solution (Fu et 
al., 2010). These suggested that the contribution of NCX to Ca2+ transients becomes more 
important as development proceeds in ESC-CMs.  
2.3.2 Sarcoplasmic/endoplasmic reticulum Ca
2+
-ATPase (SERCA) 
Details of the structure and function relationship of SERCA have been extensively reviewed 
(Periasamy et al., 2008; Periasamy and Huke, 2001; Toyoshima, 2008; Toyoshima and Inesi, 
2004; Wuytack et al., 2002). SERCA is a single polypeptide with ~1000 amino acid residues 
located on the ER/SR membrane. It consists of 10 transmembrane (M) domains and 3 
cytosolic domains, including actuator (A) domain, phosphorylation (P) domain, and 
nucleotide-binding (N) domain. A domain regulates the Ca2+ binding and release. N domain 
is connected to the P domain; it contains the adenosine binding site and forms the catalytic 
site. On the other hand, the -phosphate reacts with an amino acid residue in the P domain. 
SERCA utilizes the energy derived from ATP hydrolysis to pump Ca2+ against concentration 
gradient from the cytosol to the lumen of ER/SR. Two Ca2+ are transported by hydrolysis of 
one ATP in each catalytic cycle.  
Regulation of SERCA is mainly achieved by the action of SR membrane proteins 
phospholamban and sarcolipin (Asahi et al., 2003a; Edes and Kranias, 1987; MacLennan et 
al., 2002; MacLennan and Kranias, 2003; Simmerman and Jones, 1998; Traaseth et al., 2008). 
De-phosphorylated form of phospholamban interacts with SERCA and inhibits the 
pumping activities by decreasing the Ca2+ affinity of SERCA. Phospholamban exists in 
monomeric or pentameric form, while the monomeric form is inhibitory. Phosphorylation of 
phospholamban favors the formation of pentameric form, which in turns relieves the 
inhibitory effect on SERCA. Phosphorylation of phospholamban is regulated by cAMP-
dependent protein kinase (Schwinger et al., 1998) and Ca2+/calmodulin-dependent kinase (Ji 
et al., 2003). Sarcolipin is a shorter homolog of phospholamban (Hellstern et al., 2001). 
Unlike phospholamban, sarcolipin has no obvious phosphorylation site (Odermatt et al., 
1997); therefore, the effect of sarcolipin on SERCA inhibition is mainly controlled by altering 
the expression level of sarcolipin (Odermatt et al., 1998). Sarcolipin interacts directly with 
SERCA and inhibits its function by decreasing the Ca2+ affinity of SERCA. Sarcolipin can 
also exert its superinhibitory effect on SERCA by forming the tertiary complex 
phospholamban-sarcolipin-SERCA (Asahi et al., 2002; Asahi et al., 2003b). In addition, 
sarcolipin stabilizes the SERCA-phospholamban complex in the absence of phospholamban 
phosphorylation and also inhibits phospholamban phosphorylation (Asahi et al., 2004). 
SERCA plays a vital role in Ca2+ cycling between SR and cytosol, and this is important for 
EC-coupling. Over-expression of SERCA2a improved cardiac contractility by increasing SR 
Ca2+ loading and frequency of Ca2+ transients (Baker et al., 1998; He et al., 1997; Maier et al., 
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2005; Prasad et al., 2004). On the other hand, homozygous SERCA2a knockout mice are 
embryonic lethal (Periasamy et al., 1999), while heterozygous knockout mice are alive and 
able to reproduce (Shull et al., 2003). Ji et al. has reported that the content of SR Ca2+ stores 
and the amplitude of Ca2+ transients were decreased by 40-60% and ~30-40%, respectively, 
in heterozygous CMs (Ji et al., 2000). Interestingly, heterozygous CMs showed a reduced 
phospholamban expression, an enhanced phospholamban phosphorylation, and an 
upregulated NCX expression. However, these changes in Ca2+ handling proteins were not 
sufficient to compensate the effects on contractility by the loss of SERCA2a, indicating that 
SERCA2a is a critical regulator in controlling the E-C coupling of CMs (Ji et al., 2000). Apart 
from genetic manipulation of the expression level of SERCA, function of SERCA can also be 
assessed by using the pharmacological blocker thapsigargin. Acute application of 
thapsigargin caused the decrease in Ca2+ transient amplitude, rate of decay of Ca2+ 
transients, and duration of action potential in isolated ventricular myocytes (Kirby et al., 
1992), again suggesting the involvement of SERCA in the E-C coupling of CMs. 
In vertebrates, SERCA is encoded by three genes, including the SERCA1, SERCA2, and 
SERCA3. Alternative splicing of the transcripts from these genes produces more than 10 
SERCA isoforms. In CMs, SERCA2a and SERCA2b are expressed, with SERCA2a being the 
predominant form (Periasamy and Kalyanasundaram, 2007).  
SERCA2a mRNA is present before initial contraction of mESC-CMs, but has no obvious 
change in expression level during further differentiation (Fu et al., 2006b). From embryo 
studies, SERCA2 protein increased from E9.5 to E18 in mouse heart (Liu et al., 2002). In 
human, it was reported that SERCA2a protein level remained steady between 8 to 15th week 
gestation, and started to increase afterwards (Qu and Boutjdir, 2001). Role of SERCA in 
regulating Ca2+ transients in ESC-CMs has been studied by several groups. Zhu et al. 
demonstrated that SERCA inhibitors, including thapsigargin and cyclopiazonic acid, 
reduced ~70% amplitude of Ca2+ transients in hESC-CMs, but had no effect on the time of 
decay (Zhu et al., 2009). In case of mESC-CMs, thapsigargin reduced both the amplitude and 
decay of Ca2+ transients, but exerted similar inhibitory effect on CMs from the 3 
developmental stages (Fu et al., 2006a; Fu et al., 2006b). These findings are therefore 
consistent with the mRNA expression level of SERCA during mESC-CM differentiation. 
However, the contribution of Ca2+ removal by SERCA is estimated to be more important as 
differentiation proceeds based on Ca2+ imaging experiments (Kapur and Banach, 2007). 
Therefore, the role of other SR Ca2+ handling proteins cannot be neglected. For example, 
expression level of calsequestrin increases as SR matures (Fu et al., 2006a). This increases the 
capacity of SR Ca2+ load and may account for the requirement of greater contribution of Ca2+ 
removal by SERCA in later developmental stage of mESC-CMs. 
To summarize for the whole chapter, Figure 1 represents a summary of the relative 
contributions of different proteins responsible for regulating Ca2+ transients in early 
differentiating ESC-CMs as development proceeds.  
3. Conclusion 
In summary, early differentiating ESC-CMs have already developed a scheme for regulating 
their [Ca2+]i for E-C coupling. The relative contributions of the proteins that regulate Ca2+ 
transients alter upon the maturation of CMs. By comparing the regulation of [Ca2+]i in ESC-
CMs and that in adult CMs, we can obtain important insights into the potential strategies for 
‘fine-tuning’ ESC-CMs to better-suit different therapeutic and research purposes.  
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Fig. 1. Summary of the regulation of Ca2+ transients in CMs at early differentiation stage 
(EDS) and late differentiation stage (LDS). Number of a particular protein represents the 
relative changes in the expression level of that particular protein as differentiation proceeds. 
Thickness of the arrows represents the relative contribution of a particular path to the Ca2+ 
transients as differentiation proceeds.  
www.intechopen.com
 
Maintenance Of Calcium Homeostasis in Embryonic Stem Cell-Derived Cardiomyocytes 
 
217 
4. Acknowledgements 
When writing up this book chapter, due to space limitations, we were unable to include all 
the important studies in the field related to calcium homeostasis in ESC-CMs; we apologize 
to those investigators whom we may have missed here. I. C. Lo and C. K. Wong contributed 
equally to this work. I. C. Lo and C. K. Wong were supported by postgraduate studentships 
from the Chinese University of Hong Kong (CUHK). This work was supported by the 
Competitive Earmarked Research Grant (474907) from the University Grants Committee of 
the Hong Kong Special Administrative Region and the Focused Investment Scheme 
(1901073) from the CUHK.  
5. References 
Acosta L, Haase H, Morano I, Moorman AF, Franco D. 2004. Regional expression of L-type 
calcium channel subunits during cardiac development. Dev Dyn 230(1):131-136. 
Ai X, Curran JW, Shannon TR, Bers DM, Pogwizd SM. 2005. Ca2+/calmodulin-dependent 
protein kinase modulates cardiac ryanodine receptor phosphorylation and 
sarcoplasmic reticulum Ca2+ leak in heart failure. Circ Res 97(12):1314-1322. 
Arikkath J, Campbell KP. 2003. Auxiliary subunits: essential components of the voltage-
gated calcium channel complex. Curr Opin Neurobiol 13(3):298-307. 
Asahi M, Kurzydlowski K, Tada M, MacLennan DH. 2002. Sarcolipin inhibits 
polymerization of phospholamban to induce superinhibition of sarco(endo)plasmic 
reticulum Ca2+-ATPases (SERCAs). J Biol Chem 277(30):26725-26728. 
Asahi M, Nakayama H, Tada M, Otsu K. 2003a. Regulation of sarco(endo)plasmic reticulum 
Ca2+ adenosine triphosphatase by phospholamban and sarcolipin: implication for 
cardiac hypertrophy and failure. Trends Cardiovasc Med 13(4):152-157. 
Asahi M, Otsu K, Nakayama H, Hikoso S, Takeda T, Gramolini AO, Trivieri MG, Oudit GY, 
Morita T, Kusakari Y, Hirano S, Hongo K, Hirotani S, Yamaguchi O, Peterson A, 
Backx PH, Kurihara S, Hori M, MacLennan DH. 2004. Cardiac-specific 
overexpression of sarcolipin inhibits sarco(endo)plasmic reticulum Ca2+ ATPase 
(SERCA2a) activity and impairs cardiac function in mice. Proc Natl Acad Sci U S A 
101(25):9199-9204. 
Asahi M, Sugita Y, Kurzydlowski K, De Leon S, Tada M, Toyoshima C, MacLennan DH. 
2003b. Sarcolipin regulates sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) 
by binding to transmembrane helices alone or in association with phospholamban. 
Proc Natl Acad Sci U S A 100(9):5040-5045. 
Baker DL, Hashimoto K, Grupp IL, Ji Y, Reed T, Loukianov E, Grupp G, Bhagwhat A, Hoit 
B, Walsh R, Marban E, Periasamy M. 1998. Targeted overexpression of the 
sarcoplasmic reticulum Ca2+-ATPase increases cardiac contractility in transgenic 
mouse hearts. Circ Res 83(12):1205-1214. 
Bare DJ, Kettlun CS, Liang M, Bers DM, Mignery GA. 2005. Cardiac type 2 inositol 1,4,5-
trisphosphate receptor: interaction and modulation by calcium/calmodulin-
dependent protein kinase II. J Biol Chem 280(16):15912-15920. 
Bers DM. 2002. Cardiac excitation-contraction coupling. Nature 415(6868):198-205. 
Bers DM. 2004. Macromolecular complexes regulating cardiac ryanodine receptor function. J 
Mol Cell Cardiol 37(2):417-429. 
www.intechopen.com
 
Embryonic Stem Cells – Differentiation and Pluripotent Alternatives  
 
218 
Boheler KR, Czyz J, Tweedie D, Yang HT, Anisimov SV, Wobus AM. 2002. Differentiation of 
pluripotent embryonic stem cells into cardiomyocytes. Circ Res 91(3):189-201. 
Bohn G, Moosmang S, Conrad H, Ludwig A, Hofmann F, Klugbauer N. 2000. Expression of 
T- and L-type calcium channel mRNA in murine sinoatrial node. FEBS Lett 
481(1):73-76. 
Catterall WA. 1995. Structure and function of voltage-gated ion channels. Annu Rev 
Biochem 64:493-531. 
Catterall WA. 2000. Structure and regulation of voltage-gated Ca2+ channels. Annu Rev Cell 
Dev Biol 16:521-555. 
Catterall WA, Perez-Reyes E, Snutch TP, Striessnig J. 2005. International Union of 
Pharmacology. XLVIII. Nomenclature and structure-function relationships of 
voltage-gated calcium channels. Pharmacol Rev 57(4):411-425. 
Chen CC, Lamping KG, Nuno DW, Barresi R, Prouty SJ, Lavoie JL, Cribbs LL, England SK, 
Sigmund CD, Weiss RM, Williamson RA, Hill JA, Campbell KP. 2003. Abnormal 
coronary function in mice deficient in alpha1H T-type Ca2+ channels. Science 
302(5649):1416-1418. 
Cho CH, Kim SS, Jeong MJ, Lee CO, Shin HS. 2000. The Na+ -Ca2+ exchanger is essential for 
embryonic heart development in mice. Mol Cells 10(6):712-722. 
Cribbs LL, Martin BL, Schroder EA, Keller BB, Delisle BP, Satin J. 2001. Identification of the 
t-type calcium channel (Ca(v)3.1d) in developing mouse heart. Circ Res 88(4):403-
407. 
De Waard M, Gurnett CA, Campbell KP. 1996. Structural and functional diversity of 
voltage-activated calcium channels. Ion Channels 4:41-87. 
DiPolo R. 1979. Calcium influx in internally dialyzed squid giant axons. J Gen Physiol 
73(1):91-113. 
Dolphin AC. 2006. A short history of voltage-gated calcium channels. Br J Pharmacol 147 
Suppl 1:S56-62. 
Dolphin AC, Wyatt CN, Richards J, Beattie RE, Craig P, Lee JH, Cribbs LL, Volsen SG, 
Perez-Reyes E. 1999. The effect of alpha2-delta and other accessory subunits on 
expression and properties of the calcium channel alpha1G. J Physiol 519 Pt 1:35-45. 
Dubel SJ, Altier C, Chaumont S, Lory P, Bourinet E, Nargeot J. 2004. Plasma membrane 
expression of T-type calcium channel alpha(1) subunits is modulated by high 
voltage-activated auxiliary subunits. J Biol Chem 279(28):29263-29269. 
Edes I, Kranias EG. 1987. Regulation of cardiac sarcoplasmic reticulum function by 
phospholamban. Membr Biochem 7(3):175-192. 
Foskett JK, White C, Cheung KH, Mak DO. 2007. Inositol trisphosphate receptor Ca2+ 
release channels. Physiol Rev 87(2):593-658. 
Freise D, Himmerkus N, Schroth G, Trost C, Weissgerber P, Freichel M, Flockerzi V. 1999. 
Mutations of calcium channel beta subunit genes in mice. Biol Chem 380(7-8):897-
902. 
Fu JD, Jiang P, Rushing S, Liu J, Chiamvimonvat N, Li RA. 2010. Na+/Ca2+ exchanger is a 
determinant of excitation-contraction coupling in human embryonic stem cell-
derived ventricular cardiomyocytes. Stem Cells Dev 19(6):773-782. 
Fu JD, Li J, Tweedie D, Yu HM, Chen L, Wang R, Riordon DR, Brugh SA, Wang SQ, Boheler 
KR, Yang HT. 2006a. Crucial role of the sarcoplasmic reticulum in the 
www.intechopen.com
 
Maintenance Of Calcium Homeostasis in Embryonic Stem Cell-Derived Cardiomyocytes 
 
219 
developmental regulation of Ca2+ transients and contraction in cardiomyocytes 
derived from embryonic stem cells. FASEB J 20(1):181-183. 
Fu JD, Yu HM, Wang R, Liang J, Yang HT. 2006b. Developmental regulation of intracellular 
calcium transients during cardiomyocyte differentiation of mouse embryonic stem 
cells. Acta Pharmacol Sin 27(7):901-910. 
Gaughan JP, Furukawa S, Jeevanandam V, Hefner CA, Kubo H, Margulies KB, McGowan 
BS, Mattiello JA, Dipla K, Piacentino V, 3rd, Li S, Houser SR. 1999. Sodium/calcium 
exchange contributes to contraction and relaxation in failed human ventricular 
myocytes. Am J Physiol 277(2 Pt 2):H714-724. 
Giladi M, Boyman L, Mikhasenko H, Hiller R, Khananshvili D. 2010. Essential role of the 
CBD1-CBD2 linker in slow dissociation of Ca2+ from the regulatory two-domain 
tandem of NCX1. J Biol Chem 285(36):28117-28125. 
Go LO, Moschella MC, Watras J, Handa KK, Fyfe BS, Marks AR. 1995. Differential 
regulation of two types of intracellular calcium release channels during end-stage 
heart failure. J Clin Invest 95(2):888-894. 
Green PJ, Warre R, Hayes PD, McNaughton NC, Medhurst AD, Pangalos M, Duckworth 
DM, Randall AD. 2001. Kinetic modification of the alpha(1I) subunit-mediated T-
type Ca(2+) channel by a human neuronal Ca(2+) channel gamma subunit. J 
Physiol 533(Pt 2):467-478. 
He H, Giordano FJ, Hilal-Dandan R, Choi DJ, Rockman HA, McDonough PM, Bluhm WF, 
Meyer M, Sayen MR, Swanson E, Dillmann WH. 1997. Overexpression of the rat 
sarcoplasmic reticulum Ca2+ ATPase gene in the heart of transgenic mice 
accelerates calcium transients and cardiac relaxation. J Clin Invest 100(2):380-389. 
He JQ, Ma Y, Lee Y, Thomson JA, Kamp TJ. 2003. Human embryonic stem cells develop into 
multiple types of cardiac myocytes: action potential characterization. Circ Res 
93(1):32-39. 
Hellstern S, Pegoraro S, Karim CB, Lustig A, Thomas DD, Moroder L, Engel J. 2001. 
Sarcolipin, the shorter homologue of phospholamban, forms oligomeric structures 
in detergent micelles and in liposomes. J Biol Chem 276(33):30845-30852. 
Hess P, Lansman JB, Tsien RW. 1984. Different modes of Ca channel gating behaviour 
favoured by dihydropyridine Ca agonists and antagonists. Nature 311(5986):538-
544. 
Hilgemann DW. 1990. Regulation and deregulation of cardiac Na(+)-Ca2+ exchange in giant 
excised sarcolemmal membrane patches. Nature 344(6263):242-245. 
Hilgemann DW, Matsuoka S, Nagel GA, Collins A. 1992. Steady-state and dynamic 
properties of cardiac sodium-calcium exchange. Sodium-dependent inactivation. J 
Gen Physiol 100(6):905-932. 
Hirota S, Pertens E, Janssen LJ. 2007. The reverse mode of the Na(+)/Ca(2+) exchanger 
provides a source of Ca(2+) for store refilling following agonist-induced Ca(2+) 
mobilization. Am J Physiol Lung Cell Mol Physiol 292(2):L438-447. 
Hobom M, Dai S, Marais E, Lacinova L, Hofmann F, Klugbauer N. 2000. Neuronal 
distribution and functional characterization of the calcium channel alpha2delta-2 
subunit. Eur J Neurosci 12(4):1217-1226. 
Hosey MM, Chien AJ, Puri TS. 1996. Structure and regulation of L-type calcium channels a 
current assessment of the properties and roles of channel subunits. Trends 
Cardiovasc Med 6(8):265-273. 
www.intechopen.com
 
Embryonic Stem Cells – Differentiation and Pluripotent Alternatives  
 
220 
Iino M. 1990. Biphasic Ca2+ dependence of inositol 1,4,5-trisphosphate-induced Ca release 
in smooth muscle cells of the guinea pig taenia caeci. J Gen Physiol 95(6):1103-1122. 
Iwai M, Michikawa T, Bosanac I, Ikura M, Mikoshiba K. 2007. Molecular basis of the 
isoform-specific ligand-binding affinity of inositol 1,4,5-trisphosphate receptors. J 
Biol Chem 282(17):12755-12764. 
Iwamoto T, Pan Y, Nakamura TY, Wakabayashi S, Shigekawa M. 1998. Protein kinase C-
dependent regulation of Na+/Ca2+ exchanger isoforms NCX1 and NCX3 does not 
require their direct phosphorylation. Biochemistry 37(49):17230-17238. 
Iwamoto T, Pan Y, Wakabayashi S, Imagawa T, Yamanaka HI, Shigekawa M. 1996. 
Phosphorylation-dependent regulation of cardiac Na+/Ca2+ exchanger via protein 
kinase C. J Biol Chem 271(23):13609-13615. 
Ji Y, Lalli MJ, Babu GJ, Xu Y, Kirkpatrick DL, Liu LH, Chiamvimonvat N, Walsh RA, Shull 
GE, Periasamy M. 2000. Disruption of a single copy of the SERCA2 gene results in 
altered Ca2+ homeostasis and cardiomyocyte function. J Biol Chem 275(48):38073-
38080. 
Ji Y, Li B, Reed TD, Lorenz JN, Kaetzel MA, Dedman JR. 2003. Targeted inhibition of 
Ca2+/calmodulin-dependent protein kinase II in cardiac longitudinal sarcoplasmic 
reticulum results in decreased phospholamban phosphorylation at threonine 17. J 
Biol Chem 278(27):25063-25071. 
Kapur N, Banach K. 2007. Inositol-1,4,5-trisphosphate-mediated spontaneous activity in 
mouse embryonic stem cell-derived cardiomyocytes. J Physiol 581(Pt 3):1113-1127. 
Kehat I, Gepstein A, Spira A, Itskovitz-Eldor J, Gepstein L. 2002. High-resolution 
electrophysiological assessment of human embryonic stem cell-derived 
cardiomyocytes: a novel in vitro model for the study of conduction. Circ Res 
91(8):659-661. 
Kehat I, Kenyagin-Karsenti D, Snir M, Segev H, Amit M, Gepstein A, Livne E, Binah O, 
Itskovitz-Eldor J, Gepstein L. 2001. Human embryonic stem cells can differentiate 
into myocytes with structural and functional properties of cardiomyocytes. J Clin 
Invest 108(3):407-414. 
Kirby MS, Sagara Y, Gaa S, Inesi G, Lederer WJ, Rogers TB. 1992. Thapsigargin inhibits 
contraction and Ca2+ transient in cardiac cells by specific inhibition of the 
sarcoplasmic reticulum Ca2+ pump. J Biol Chem 267(18):12545-12551. 
Kolossov E, Fleischmann BK, Liu Q, Bloch W, Viatchenko-Karpinski S, Manzke O, Ji GJ, 
Bohlen H, Addicks K, Hescheler J. 1998. Functional characteristics of ES cell-
derived cardiac precursor cells identified by tissue-specific expression of the green 
fluorescent protein. J Cell Biol 143(7):2045-2056. 
Koushik SV, Wang J, Rogers R, Moskophidis D, Lambert NA, Creazzo TL, Conway SJ. 2001. 
Targeted inactivation of the sodium-calcium exchanger (Ncx1) results in the lack of 
a heartbeat and abnormal myofibrillar organization. FASEB J 15(7):1209-1211. 
Lacinova L, Klugbauer N. 2004. Modulation of gating currents of the Ca(v)3.1 calcium 
channel by alpha 2 delta 2 and gamma 5 subunits. Arch Biochem Biophys 
425(2):207-213. 
Lanner JT, Georgiou DK, Joshi AD, Hamilton SL. 2010. Ryanodine receptors: structure, 
expression, molecular details, and function in calcium release. Cold Spring Harb 
Perspect Biol 2(11):a003996. 
www.intechopen.com
 
Maintenance Of Calcium Homeostasis in Embryonic Stem Cell-Derived Cardiomyocytes 
 
221 
Lee SL, Yu AS, Lytton J. 1994. Tissue-specific expression of Na(+)-Ca2+ exchanger isoforms. 
J Biol Chem 269(21):14849-14852. 
Li X, Zima AV, Sheikh F, Blatter LA, Chen J. 2005. Endothelin-1-induced arrhythmogenic 
Ca2+ signaling is abolished in atrial myocytes of inositol-1,4,5-trisphosphate(IP3)-
receptor type 2-deficient mice. Circ Res 96(12):1274-1281. 
Liu W, Yasui K, Opthof T, Ishiki R, Lee JK, Kamiya K, Yokota M, Kodama I. 2002. 
Developmental changes of Ca(2+) handling in mouse ventricular cells from early 
embryo to adulthood. Life Sci 71(11):1279-1292. 
Ma J, Hayek SM, Bhat MB. 2004. Membrane topology and membrane retention of the 
ryanodine receptor calcium release channel. Cell Biochem Biophys 40(2):207-224. 
MacLennan DH, Abu-Abed M, Kang C. 2002. Structure-function relationships in Ca(2+) 
cycling proteins. J Mol Cell Cardiol 34(8):897-918. 
MacLennan DH, Kranias EG. 2003. Phospholamban: a crucial regulator of cardiac 
contractility. Nat Rev Mol Cell Biol 4(7):566-577. 
Maier LS, Wahl-Schott C, Horn W, Weichert S, Pagel C, Wagner S, Dybkova N, Muller OJ, 
Nabauer M, Franz WM, Pieske B. 2005. Increased SR Ca2+ cycling contributes to 
improved contractile performance in SERCA2a-overexpressing transgenic rats. 
Cardiovasc Res 67(4):636-646. 
Mangoni ME, Traboulsie A, Leoni AL, Couette B, Marger L, Le Quang K, Kupfer E, Cohen-
Solal A, Vilar J, Shin HS, Escande D, Charpentier F, Nargeot J, Lory P. 2006. 
Bradycardia and slowing of the atrioventricular conduction in mice lacking 
CaV3.1/alpha1G T-type calcium channels. Circ Res 98(11):1422-1430. 
Matsuoka S, Nicoll DA, He Z, Philipson KD. 1997. Regulation of cardiac Na(+)-Ca2+ 
exchanger by the endogenous XIP region. J Gen Physiol 109(2):273-286. 
Mery A, Aimond F, Menard C, Mikoshiba K, Michalak M, Puceat M. 2005. Initiation of 
embryonic cardiac pacemaker activity by inositol 1,4,5-trisphosphate-dependent 
calcium signaling. Mol Biol Cell 16(5):2414-2423. 
Mizuta E, Miake J, Yano S, Furuichi H, Manabe K, Sasaki N, Igawa O, Hoshikawa Y, 
Shigemasa C, Nanba E, Ninomiya H, Hidaka K, Morisaki T, Tajima F, Hisatome I. 
2005. Subtype switching of T-type Ca 2+ channels from Cav3.2 to Cav3.1 during 
differentiation of embryonic stem cells to cardiac cell lineage. Circ J 69(10):1284-
1289. 
Moore JC, Tsang SY, Rushing SN, Lin D, Tse HF, Chan CW, Li RA. 2008. Functional 
consequences of overexpressing the gap junction Cx43 in the cardiogenic potential 
of pluripotent human embryonic stem cells. Biochem Biophys Res Commun 
377(1):46-51. 
Moreno Davila H. 1999. Molecular and functional diversity of voltage-gated calcium 
channels. Ann N Y Acad Sci 868:102-117. 
Moschella MC, Marks AR. 1993. Inositol 1,4,5-trisphosphate receptor expression in cardiac 
myocytes. J Cell Biol 120(5):1137-1146. 
Mummery C, Ward-van Oostwaard D, Doevendans P, Spijker R, van den Brink S, Hassink 
R, van der Heyden M, Opthof T, Pera M, de la Riviere AB, Passier R, Tertoolen L. 
2003. Differentiation of human embryonic stem cells to cardiomyocytes: role of 
coculture with visceral endoderm-like cells. Circulation 107(21):2733-2740. 
www.intechopen.com
 
Embryonic Stem Cells – Differentiation and Pluripotent Alternatives  
 
222 
Nakayama H, Bodi I, Maillet M, DeSantiago J, Domeier TL, Mikoshiba K, Lorenz JN, Blatter 
LA, Bers DM, Molkentin JD. 2010. The IP3 receptor regulates cardiac hypertrophy 
in response to select stimuli. Circ Res 107(5):659-666. 
Nakazawa M, Uchida K, Aramaki M, Kodo K, Yamagishi C, Takahashi T, Mikoshiba K, 
Yamagishi H. 2011. Inositol 1,4,5-trisphosphate receptors are essential for the 
development of the second heart field. J Mol Cell Cardiol. 
Ng SY, Wong CK, Tsang SY. 2010. Differential gene expressions in atrial and ventricular 
myocytes: insights into the road of applying embryonic stem cell-derived 
cardiomyocytes for future therapies. Am J Physiol Cell Physiol 299(6):C1234-1249. 
Nicoll DA, Hryshko LV, Matsuoka S, Frank JS, Philipson KD. 1996. Mutation of amino acid 
residues in the putative transmembrane segments of the cardiac sarcolemmal Na+-
Ca2+ exchanger. J Biol Chem 271(23):13385-13391. 
Odermatt A, Becker S, Khanna VK, Kurzydlowski K, Leisner E, Pette D, MacLennan DH. 
1998. Sarcolipin regulates the activity of SERCA1, the fast-twitch skeletal muscle 
sarcoplasmic reticulum Ca2+-ATPase. J Biol Chem 273(20):12360-12369. 
Odermatt A, Taschner PE, Scherer SW, Beatty B, Khanna VK, Cornblath DR, Chaudhry V, 
Yee WC, Schrank B, Karpati G, Breuning MH, Knoers N, MacLennan DH. 1997. 
Characterization of the gene encoding human sarcolipin (SLN), a proteolipid 
associated with SERCA1: absence of structural mutations in five patients with 
Brody disease. Genomics 45(3):541-553. 
Ono K, Iijima T. 2005. Pathophysiological significance of T-type Ca2+ channels: properties 
and functional roles of T-type Ca2+ channels in cardiac pacemaking. J Pharmacol 
Sci 99(3):197-204. 
Otsu K, Kuruma A, Yanagida E, Shoji S, Inoue T, Hirayama Y, Uematsu H, Hara Y, Kawano 
S. 2005. Na+/K+ ATPase and its functional coupling with Na+/Ca2+ exchanger in 
mouse embryonic stem cells during differentiation into cardiomyocytes. Cell 
Calcium 37(2):137-151. 
Ottolia M, Philipson KD, John S. 2004. Conformational changes of the Ca(2+) regulatory site 
of the Na(+)-Ca(2+) exchanger detected by FRET. Biophys J 87(2):899-906. 
Perez-Reyes E. 2003. Molecular physiology of low-voltage-activated t-type calcium channels. 
Physiol Rev 83(1):117-161. 
Perez-Reyes E. 2006. Molecular characterization of T-type calcium channels. Cell Calcium 
40(2):89-96. 
Periasamy M, Bhupathy P, Babu GJ. 2008. Regulation of sarcoplasmic reticulum Ca2+ 
ATPase pump expression and its relevance to cardiac muscle physiology and 
pathology. Cardiovasc Res 77(2):265-273. 
Periasamy M, Huke S. 2001. SERCA pump level is a critical determinant of 
Ca(2+)homeostasis and cardiac contractility. J Mol Cell Cardiol 33(6):1053-1063. 
Periasamy M, Kalyanasundaram A. 2007. SERCA pump isoforms: their role in calcium 
transport and disease. Muscle Nerve 35(4):430-442. 
Periasamy M, Reed TD, Liu LH, Ji Y, Loukianov E, Paul RJ, Nieman ML, Riddle T, Duffy JJ, 
Doetschman T, Lorenz JN, Shull GE. 1999. Impaired cardiac performance in 
heterozygous mice with a null mutation in the sarco(endo)plasmic reticulum Ca2+-
ATPase isoform 2 (SERCA2) gene. J Biol Chem 274(4):2556-2562. 
Philipson KD, Nicoll DA. 2000. Sodium-calcium exchange: a molecular perspective. Annu 
Rev Physiol 62:111-133. 
www.intechopen.com
 
Maintenance Of Calcium Homeostasis in Embryonic Stem Cell-Derived Cardiomyocytes 
 
223 
Platzer J, Engel J, Schrott-Fischer A, Stephan K, Bova S, Chen H, Zheng H, Striessnig J. 2000. 
Congenital deafness and sinoatrial node dysfunction in mice lacking class D L-type 
Ca2+ channels. Cell 102(1):89-97. 
Pott C, Philipson KD, Goldhaber JI. 2005. Excitation-contraction coupling in Na+-Ca2+ 
exchanger knockout mice: reduced transsarcolemmal Ca2+ flux. Circ Res 
97(12):1288-1295. 
Prasad V, Okunade GW, Miller ML, Shull GE. 2004. Phenotypes of SERCA and PMCA 
knockout mice. Biochem Biophys Res Commun 322(4):1192-1203. 
Qu Y, Baroudi G, Yue Y, El-Sherif N, Boutjdir M. 2005. Localization and modulation of 
{alpha}1D (Cav1.3) L-type Ca channel by protein kinase A. Am J Physiol Heart Circ 
Physiol 288(5):H2123-2130. 
Qu Y, Boutjdir M. 2001. Gene expression of SERCA2a and L- and T-type Ca channels during 
human heart development. Pediatr Res 50(5):569-574. 
Rapila R, Korhonen T, Tavi P. 2008. Excitation-contraction coupling of the mouse embryonic 
cardiomyocyte. J Gen Physiol 132(4):397-405. 
Reppel M, Fleischmann BK, Reuter H, Sasse P, Schunkert H, Hescheler J. 2007a. Regulation 
of the Na+/Ca2+ exchanger (NCX) in the murine embryonic heart. Cardiovasc Res 
75(1):99-108. 
Reppel M, Sasse P, Malan D, Nguemo F, Reuter H, Bloch W, Hescheler J, Fleischmann BK. 
2007b. Functional expression of the Na+/Ca2+ exchanger in the embryonic mouse 
heart. J Mol Cell Cardiol 42(1):121-132. 
Reuter H, Henderson SA, Han T, Mottino GA, Frank JS, Ross RS, Goldhaber JI, Philipson 
KD. 2003. Cardiac excitation-contraction coupling in the absence of Na(+) - Ca2+ 
exchange. Cell Calcium 34(1):19-26. 
Richards MW, Butcher AJ, Dolphin AC. 2004. Ca2+ channel beta-subunits: structural 
insights AID our understanding. Trends Pharmacol Sci 25(12):626-632. 
Rosemblit N, Moschella MC, Ondriasa E, Gutstein DE, Ondrias K, Marks AR. 1999. 
Intracellular calcium release channel expression during embryogenesis. Dev Biol 
206(2):163-177. 
Sah R, Ramirez RJ, Oudit GY, Gidrewicz D, Trivieri MG, Zobel C, Backx PH. 2003. 
Regulation of cardiac excitation-contraction coupling by action potential 
repolarization: role of the transient outward potassium current (I(to)). J Physiol 
546(Pt 1):5-18. 
Satin J, Itzhaki I, Rapoport S, Schroder EA, Izu L, Arbel G, Beyar R, Balke CW, Schiller J, 
Gepstein L. 2008. Calcium handling in human embryonic stem cell-derived 
cardiomyocytes. Stem Cells 26(8):1961-1972. 
Sauer H, Theben T, Hescheler J, Lindner M, Brandt MC, Wartenberg M. 2001. Characteristics 
of calcium sparks in cardiomyocytes derived from embryonic stem cells. Am J 
Physiol Heart Circ Physiol 281(1):H411-421. 
Schwinger RH, Bolck B, Munch G, Brixius K, Muller-Ehmsen J, Erdmann E. 1998. cAMP-
dependent protein kinase A-stimulated sarcoplasmic reticulum function in heart 
failure. Ann N Y Acad Sci 853:240-250. 
Sedan O, Dolnikov K, Zeevi-Levin N, Fleishmann N, Spiegel I, Berdichevski S, Amit M, 
Itskovitz-Eldor J, Binah O. 2010. Human embryonic stem cell-derived 
cardiomyocytes can mobilize 1,4,5-inositol trisphosphate-operated [Ca2+]i stores: 
www.intechopen.com
 
Embryonic Stem Cells – Differentiation and Pluripotent Alternatives  
 
224 
the functionality of angiotensin-II/endothelin-1 signaling pathways. Ann N Y Acad 
Sci 1188:68-77. 
Sedan O, Dolnikov K, Zeevi-Levin N, Leibovich N, Amit M, Itskovitz-Eldor J, Binah O. 2008. 
1,4,5-Inositol trisphosphate-operated intracellular Ca(2+) stores and angiotensin-
II/endothelin-1 signaling pathway are functional in human embryonic stem cell-
derived cardiomyocytes. Stem Cells 26(12):3130-3138. 
Seisenberger C, Specht V, Welling A, Platzer J, Pfeifer A, Kuhbandner S, Striessnig J, 
Klugbauer N, Feil R, Hofmann F. 2000. Functional embryonic cardiomyocytes after 
disruption of the L-type alpha1C (Cav1.2) calcium channel gene in the mouse. J Biol 
Chem 275(50):39193-39199. 
Shull GE, Okunade G, Liu LH, Kozel P, Periasamy M, Lorenz JN, Prasad V. 2003. 
Physiological functions of plasma membrane and intracellular Ca2+ pumps 
revealed by analysis of null mutants. Ann N Y Acad Sci 986:453-460. 
Simmerman HK, Jones LR. 1998. Phospholamban: protein structure, mechanism of action, 
and role in cardiac function. Physiol Rev 78(4):921-947. 
Spencer CI, Sham JS. 2003. Effects of Na+/Ca2+ exchange induced by SR Ca2+ release on 
action potentials and afterdepolarizations in guinea pig ventricular myocytes. Am J 
Physiol Heart Circ Physiol 285(6):H2552-2562. 
Takeshima H, Komazaki S, Hirose K, Nishi M, Noda T, Iino M. 1998. Embryonic lethality 
and abnormal cardiac myocytes in mice lacking ryanodine receptor type 2. EMBO J 
17(12):3309-3316. 
Taylor CW, da Fonseca PC, Morris EP. 2004. IP(3) receptors: the search for structure. Trends 
Biochem Sci 29(4):210-219. 
Taylor CW, Laude AJ. 2002. IP3 receptors and their regulation by calmodulin and cytosolic 
Ca2+. Cell Calcium 32(5-6):321-334. 
Taylor CW, Tovey SC. 2010. IP(3) receptors: toward understanding their activation. Cold 
Spring Harb Perspect Biol 2(12):a004010. 
Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. 
1998. Embryonic stem cell lines derived from human blastocysts. Science 
282(5391):1145-1147. 
Toyoshima C. 2008. Structural aspects of ion pumping by Ca2+-ATPase of sarcoplasmic 
reticulum. Arch Biochem Biophys 476(1):3-11. 
Toyoshima C, Inesi G. 2004. Structural basis of ion pumping by Ca2+-ATPase of the 
sarcoplasmic reticulum. Annu Rev Biochem 73:269-292. 
Traaseth NJ, Ha KN, Verardi R, Shi L, Buffy JJ, Masterson LR, Veglia G. 2008. Structural and 
dynamic basis of phospholamban and sarcolipin inhibition of Ca(2+)-ATPase. 
Biochemistry 47(1):3-13. 
Tu H, Wang Z, Nosyreva E, De Smedt H, Bezprozvanny I. 2005. Functional characterization 
of mammalian inositol 1,4,5-trisphosphate receptor isoforms. Biophys J 88(2):1046-
1055. 
Uchida K, Aramaki M, Nakazawa M, Yamagishi C, Makino S, Fukuda K, Nakamura T, 
Takahashi T, Mikoshiba K, Yamagishi H. 2010. Gene knock-outs of inositol 1,4,5-
trisphosphate receptors types 1 and 2 result in perturbation of cardiogenesis. PLoS 
One 5(9). 
Viatchenko-Karpinski S, Fleischmann BK, Liu Q, Sauer H, Gryshchenko O, Ji GJ, Hescheler 
J. 1999. Intracellular Ca2+ oscillations drive spontaneous contractions in 
www.intechopen.com
 
Maintenance Of Calcium Homeostasis in Embryonic Stem Cell-Derived Cardiomyocytes 
 
225 
cardiomyocytes during early development. Proc Natl Acad Sci U S A 96(14):8259-
8264. 
Wakimoto K, Kobayashi K, Kuro OM, Yao A, Iwamoto T, Yanaka N, Kita S, Nishida A, 
Azuma S, Toyoda Y, Omori K, Imahie H, Oka T, Kudoh S, Kohmoto O, Yazaki Y, 
Shigekawa M, Imai Y, Nabeshima Y, Komuro I. 2000. Targeted disruption of 
Na+/Ca2+ exchanger gene leads to cardiomyocyte apoptosis and defects in 
heartbeat. J Biol Chem 275(47):36991-36998. 
Wang J, Chan TO, Zhang XQ, Gao E, Song J, Koch WJ, Feldman AM, Cheung JY. 2009. 
Induced overexpression of Na+/Ca2+ exchanger transgene: altered myocyte 
contractility, [Ca2+]i transients, SR Ca2+ contents, and action potential duration. 
Am J Physiol Heart Circ Physiol 297(2):H590-601. 
Wanichawan P, Louch WE, Hortemo KH, Austbo B, Lunde PK, Scott JD, Sejersted OM, 
Carlson CR. 2011. Full-length cardiac Na+/Ca2+ exchanger 1 protein is not 
phosphorylated by protein kinase A. Am J Physiol Cell Physiol 300(5):C989-997. 
Wu M, Le HD, Wang M, Yurkov V, Omelchenko A, Hnatowich M, Nix J, Hryshko LV, 
Zheng L. 2010. Crystal structures of progressive Ca2+ binding states of the Ca2+ 
sensor Ca2+ binding domain 1 (CBD1) from the CALX Na+/Ca2+ exchanger reveal 
incremental conformational transitions. J Biol Chem 285(4):2554-2561. 
Wuytack F, Raeymaekers L, Missiaen L. 2002. Molecular physiology of the SERCA and 
SPCA pumps. Cell Calcium 32(5-6):279-305. 
Xu C, Police S, Rao N, Carpenter MK. 2002. Characterization and enrichment of 
cardiomyocytes derived from human embryonic stem cells. Circ Res 91(6):501-508. 
Xu M, Welling A, Paparisto S, Hofmann F, Klugbauer N. 2003. Enhanced expression of L-
type Cav1.3 calcium channels in murine embryonic hearts from Cav1.2-deficient 
mice. J Biol Chem 278(42):40837-40841. 
Xue T, Cho HC, Akar FG, Tsang SY, Jones SP, Marban E, Tomaselli GF, Li RA. 2005. 
Functional integration of electrically active cardiac derivatives from genetically 
engineered human embryonic stem cells with quiescent recipient ventricular 
cardiomyocytes: insights into the development of cell-based pacemakers. 
Circulation 111(1):11-20. 
Yanagi K, Takano M, Narazaki G, Uosaki H, Hoshino T, Ishii T, Misaki T, Yamashita JK. 
2007. Hyperpolarization-activated cyclic nucleotide-gated channels and T-type 
calcium channels confer automaticity of embryonic stem cell-derived 
cardiomyocytes. Stem Cells 25(11):2712-2719. 
Yanagida E, Shoji S, Hirayama Y, Yoshikawa F, Otsu K, Uematsu H, Hiraoka M, Furuichi T, 
Kawano S. 2004. Functional expression of Ca2+ signaling pathways in mouse 
embryonic stem cells. Cell Calcium 36(2):135-146. 
Yang HT, Tweedie D, Wang S, Guia A, Vinogradova T, Bogdanov K, Allen PD, Stern MD, 
Lakatta EG, Boheler KR. 2002. The ryanodine receptor modulates the spontaneous 
beating rate of cardiomyocytes during development. Proc Natl Acad Sci U S A 
99(14):9225-9230. 
Yang L, Katchman A, Morrow JP, Doshi D, Marx SO. 2011. Cardiac L-type calcium channel 
(Cav1.2) associates with gamma subunits. FASEB J 25(3):928-936. 
Yasui K, Niwa N, Takemura H, Opthof T, Muto T, Horiba M, Shimizu A, Lee JK, Honjo H, 
Kamiya K, Kodama I. 2005. Pathophysiological significance of T-type Ca2+ 
www.intechopen.com
 
Embryonic Stem Cells – Differentiation and Pluripotent Alternatives  
 
226 
channels: expression of T-type Ca2+ channels in fetal and diseased heart. J 
Pharmacol Sci 99(3):205-210. 
Yule DI, Betzenhauser MJ, Joseph SK. 2010. Linking structure to function: Recent lessons 
from inositol 1,4,5-trisphosphate receptor mutagenesis. Cell Calcium 47(6):469-479. 
Zhang YM, Shang L, Hartzell C, Narlow M, Cribbs L, Dudley SC, Jr. 2003. Characterization 
and regulation of T-type Ca2+ channels in embryonic stem cell-derived 
cardiomyocytes. Am J Physiol Heart Circ Physiol 285(6):H2770-2779. 
Zhang Z, Xu Y, Song H, Rodriguez J, Tuteja D, Namkung Y, Shin HS, Chiamvimonvat N. 
2002. Functional Roles of Ca(v)1.3 (alpha(1D)) calcium channel in sinoatrial nodes: 
insight gained using gene-targeted null mutant mice. Circ Res 90(9):981-987. 
Zhu WZ, Santana LF, Laflamme MA. 2009. Local control of excitation-contraction coupling 
in human embryonic stem cell-derived cardiomyocytes. PLoS One 4(4):e5407. 
www.intechopen.com
Embryonic Stem Cells - Differentiation and Pluripotent Alternatives
Edited by Prof. Michael S. Kallos
ISBN 978-953-307-632-4
Hard cover, 506 pages
Publisher InTech
Published online 12, October, 2011
Published in print edition October, 2011
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
The ultimate clinical implementation of embryonic stem cells will require methods and protocols to turn these
unspecialized cells into the fully functioning cell types found in a wide variety of tissues and organs. In order to
achieve this, it is necessary to clearly understand the signals and cues that direct embryonic stem cell
differentiation. This book provides a snapshot of current research on the differentiation of embryonic stem cells
to a wide variety of cell types, including neural, cardiac, endothelial, osteogenic, and hepatic cells. In addition,
induced pluripotent stem cells and other pluripotent stem cell sources are described. The book will serve as a
valuable resource for engineers, scientists, and clinicians as well as students in a wide range of disciplines.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Iek Chi Lo, Chun Kit Wong and Suk Ying Tsang (2011). Maintenance Of Calcium Homeostasis in Embryonic
Stem Cell-Derived Cardiomyocytes, Embryonic Stem Cells - Differentiation and Pluripotent Alternatives, Prof.
Michael S. Kallos (Ed.), ISBN: 978-953-307-632-4, InTech, Available from:
http://www.intechopen.com/books/embryonic-stem-cells-differentiation-and-pluripotent-
alternatives/maintenance-of-calcium-homeostasis-in-embryonic-stem-cell-derived-cardiomyocytes
© 2011 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
